Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | AMGN | GILD | BIIB | CELG |
| Company | Crispr Therapeutics Ag | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 56.35 | 310.88 | 64.78 | 219.23 | 108.01 |
| High | 57.16 | 312.73 | 65.12 | 221.48 | 108.59 |
| Low | 55.82 | 297.52 | 64.34 | 218.29 | 107.27 |
| Last | 56.60 | 298.41 | 64.46 | 219.79 | 108.24 |
| Change | +0.71 | -12.88 | -0.32 | +2.28 | +0.11 |
| % Change | +1.27% | -4.14% | -0.49% | +1.05% | +0.10% |
| Volume | 525,603 | 1,879,248 | 1,581,829 | 395,409 | 191,230,496 |
| 20-Day Average Volume | 1,264,087 | 2,641,895 | 7,249,883 | 1,325,928 | 16,188,930 |
| Previous Close | 55.89 | 311.29 | 64.78 | 217.51 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 56.91 | 273.76 | 66.63 | 203.80 | 108.17 |
| 20-Day Raw Stochastic | 27.82% | 61.98% | 1.87% | 92.23% | 63.25% |
| 20-Day Relative Strength | 39.02% | 62.40% | 29.18% | 57.57% | 64.69% |
| Weighted Alpha | -24.58 | +27.38 | -21.86 | -27.15 | +46.30 |
| Today's Opinion | 40% Sell | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 24% Buy | 8% Sell | 100% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.52% since 04/29/24 | +8.21% since 04/29/24 | -2.28% since 04/29/24 | +1.62% since 04/29/24 | -1.97% since 11/13/19 |
| Low | 52.73 on 04/30/24 | 272.35 on 04/30/24 | 64.33 on 05/03/24 | 213.11 on 05/03/24 | 107.27 on 11/20/19 |
| High | 58.45 on 05/03/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 221.48 on 05/06/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -10.64% since 04/05/24 | +10.78% since 04/05/24 | -7.39% since 04/05/24 | +7.42% since 04/05/24 | +5.14% since 10/18/19 |
| Low | 52.73 on 04/30/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 65.24 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 221.48 on 05/06/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -15.95% since 02/06/24 | -5.38% since 02/06/24 | -17.09% since 02/06/24 | -10.82% since 02/06/24 | +13.63% since 08/20/19 |
| Low | 52.73 on 04/30/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 91.10 on 02/22/24 | 322.60 on 05/03/24 | 76.45 on 02/07/24 | 246.44 on 02/07/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +8.98% since 11/06/23 | +9.61% since 11/06/23 | -20.59% since 11/06/23 | -11.92% since 11/06/23 | +14.14% since 05/20/19 |
| Low | 48.55 on 11/13/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 91.10 on 02/22/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,744,111 | 166,968,480 | 80,656,088 | 31,668,802 | 77,035,920 |
| Shares Outstanding, K | 84,883 | 536,376 | 1,245,077 | 145,597 | 711,714 |
| Annual Sales | 371,210,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -153,610,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 201,210,000 | 8,196,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
| Last Quarter Net Income | 89,350,000 | 767,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
| 60-Month Beta | 1.80 | 0.60 | 0.22 | -0.01 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.10 on 02/21/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 16.21 | 14.23 | 10.99 |